It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth

Front Endocrinol (Lausanne). 2019 Oct 29:10:738. doi: 10.3389/fendo.2019.00738. eCollection 2019.

Megan M Oberle^{1

2}, Aaron S Kelly^{1

2}

¹ Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States.
² Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.

No abstract available

Keywords: GLP-1 receptor agonists; adolescents; obesity; pedatrics; type 2 diabetes; weight management.